Justices Urged To Pass On Orexigen Disclosure Dispute
An investor in now-bankrupt Orexigen told the U.S. Supreme Court on Friday there's no need to review the Ninth Circuit's ruling that the biotechnology company had a duty to warn investors...To view the full article, register now.
Already a subscriber? Click here to view full article